| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/24/2012 | US20120128764 Controlled-release compositions comprising a proton pump inhibitor |
| 05/24/2012 | US20120128763 Lubricant for the ocular surface |
| 05/24/2012 | US20120128762 Sphingomyelin Liposomes for the Treatment of Hyperactive Bladder Disorders |
| 05/24/2012 | US20120128761 Lipophilic Polynucleotide Conjugates |
| 05/24/2012 | US20120128760 Lipid compositions |
| 05/24/2012 | US20120128757 Method of Manufacture of Liposome Composition |
| 05/24/2012 | US20120128754 Treatment of eye discomfort by topical administration of a cooling agent to the external surface of the eyelid |
| 05/24/2012 | US20120128753 Meditowel pre-packaged medicated muscle and joint pain relief wipe |
| 05/24/2012 | US20120128752 Multi-phase microparticles and method of manufacturing multi-phase microparticles |
| 05/24/2012 | US20120128744 Mixture containing menthol |
| 05/24/2012 | US20120128742 Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein |
| 05/24/2012 | US20120128741 Modified hyaluronic acid polymer compositions and related methods |
| 05/24/2012 | US20120128740 Nanostructured sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them |
| 05/24/2012 | US20120128738 Theobromine for the Treatment of Cough |
| 05/24/2012 | US20120128736 Oil-in-water emulsion of mometasone |
| 05/24/2012 | US20120128735 Methods of treatment using a gastric retained gabapentin dosage |
| 05/24/2012 | US20120128734 Oral Delivery Product |
| 05/24/2012 | US20120128733 Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same |
| 05/24/2012 | US20120128732 Combinations and modes of administration of therapeutic agents and combination therapy |
| 05/24/2012 | US20120128731 Biocompatible carrier and method for fabricating the same |
| 05/24/2012 | US20120128730 Compositions and methods for once-daily treatment of obsessive compulsive disorder with ondansetron |
| 05/24/2012 | US20120128729 Gallium Formulation For The Treatment And Prevention of Infectious Diseases |
| 05/24/2012 | US20120128728 Compositions Comprising Amphotericin B |
| 05/24/2012 | US20120128725 Detection/measurement of malaria infection disease utilizing natural immunity by hemozoin induction, screening of preventative or therapeutic medicine for malaria infection disease, and regulation of natural immunity induction |
| 05/24/2012 | US20120128724 Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors |
| 05/24/2012 | US20120128723 Cancer specific antibody and cell surface proteins |
| 05/24/2012 | US20120128722 Novel Monensin Derivatives for the Treatment and Prevention of Protozoal Infections |
| 05/24/2012 | US20120128715 Method for stimulating the immune response of newborns |
| 05/24/2012 | US20120128705 C6orf167 peptides and vaccines containing the same |
| 05/24/2012 | US20120128704 Repertoire of allo-restricted peptide-specific t cell receptor sequences and use thereof |
| 05/24/2012 | US20120128703 Aminopterin Dosage Forms and Methods for Inflammatory Disorders |
| 05/24/2012 | US20120128700 Constructs for delivery of therapeutic agents to neuronal cells |
| 05/24/2012 | US20120128699 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response |
| 05/24/2012 | US20120128697 NOTCH Inhibition in the Treatment or Prevention of Atherosclerosis |
| 05/24/2012 | US20120128695 Teneurin c-terminal associated peptides (tcap) and methods and uses thereof |
| 05/24/2012 | US20120128693 Cadherin-11 inhibitors and methods of use thereof |
| 05/24/2012 | US20120128690 Methods for determining agents that treat or prevent obesity and/or obesity related diseases and methods for treatment therewith |
| 05/24/2012 | US20120128688 Anti-cxcl13 and anti-cxcr5 antibodies for the prevention and treatment of cancer and cancer cell migration |
| 05/24/2012 | US20120128686 Thienopyrimidines for pharmaceutical compositions |
| 05/24/2012 | US20120128682 Apolipoprotein l- i variants and their use |
| 05/24/2012 | US20120128673 Modulation of pilr receptors to treat microbial infections |
| 05/24/2012 | US20120128670 mTOR INHIBITOR AND ANGIOGENESIS INHIBITOR COMBINATION THERAPY |
| 05/24/2012 | US20120128667 Pentamidine combinations for treating cancer |
| 05/24/2012 | US20120128665 Preselection of subjects for therapeutic treatment based on hypoxic status |
| 05/24/2012 | US20120128662 Substituted imidazoquinoxalines |
| 05/24/2012 | US20120128660 Diagnosis of restenosis in patients undergoing percutaneous coronary intervention |
| 05/24/2012 | US20120128659 Agents capable of downregulating an msf-a - dependent hif-1alpha and use thereof in cancer treatment |
| 05/24/2012 | US20120128658 Rage g82s-related methods and compositions for treating inflammatory disorders |
| 05/24/2012 | US20120128657 Synthetic macrocyclic compounds and methods for treating cancer |
| 05/24/2012 | US20120128654 Allantoin Administration for the Treatment of Neurodegenerative Disease and Neurotrauma |
| 05/24/2012 | US20120128647 Delivery of compounds with rehydrated blood cells |
| 05/24/2012 | US20120128646 Methods and compositions for the treatment of autoimmune disease |
| 05/24/2012 | US20120128630 1-(6 members azo-heterocyclic)-pyrrolin-2-one compounds as inhibitors of hepatitis c ns5b polymerase, the pharamaceutical composition thereof and their therapeutic use |
| 05/24/2012 | US20120128628 COMBINATION OF A NUCLEOSIDE POLYMERASE INHIBITOR WITH A MACROCYCLIC PROTEASE INHIBITOR AND USE THEREOF IN THE TREATMENT OF HEPATITIS C, LIVER FIBROSIS AND IMPAIRED LIVER FUNCTION (as amended) |
| 05/24/2012 | US20120128626 Anti-il-6 antibodies for the treatment of anemia |
| 05/24/2012 | US20120128625 Compounds, compositions, and methods for preventing metastasis of cancer cells |
| 05/24/2012 | US20120128622 MRSA Bactericidal Topical Gel |
| 05/24/2012 | US20120128612 Azole antifungal compositions |
| 05/24/2012 | US20120128592 Surface enhanced raman spectroscopy (sers) compounds and methods of their preparation |
| 05/24/2012 | US20120128582 Methods and compositions of [32p]-labeled adenine nucleotides for the treatment of atherosclerosis, vascular arterial diseases and coronary artery diseases |
| 05/24/2012 | US20120128580 Preselection of subjects for therapeutic treatment with elesclomol based on hypoxic status |
| 05/24/2012 | US20120126214 Methods and intermediates for the synthesis of dipyrrin-substituted porphyrinic macrocycles |
| 05/24/2012 | US20120125325 The use of amlexanox in the therapy of neutrophil-driven diseases |
| 05/24/2012 | DE102010051689A1 Dihydroxyfumarsäure-Derivate und deren Verwendung zur Hautaufhellung Dihydroxyfumaric acid derivatives and their use for skin lightening |
| 05/24/2012 | DE102010044131A1 Substituiertes Natrium-1H-pyrazol-5-olat Substituted sodium-1H-pyrazol-5-olate |
| 05/24/2012 | CA2852410A1 Nanoparticle isoflavone compositions & methods of making and using the same |
| 05/24/2012 | CA2846227A1 Treatment of type ii diabetes and diabetes-associated diseases with safe chemical mitochondrial uncouplers |
| 05/24/2012 | CA2818612A1 Therapeutic agent formulations for implanted devices |
| 05/24/2012 | CA2818563A1 Novel monensin derivatives for the treatment and prevention of protozoal infections |
| 05/24/2012 | CA2818544A1 Method of treatment with braf inhibitor |
| 05/24/2012 | CA2818542A1 Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors |
| 05/24/2012 | CA2818491A1 Methods for treating chronic or unresolvable pain and/or increasing the pain threshold in a subject and pharmaceutical compositions for use therein |
| 05/24/2012 | CA2818389A1 Substituted 4-(selenophen-2(or 3)-ylamino)pyrimidine compounds and methods of use thereof |
| 05/24/2012 | CA2818361A1 3'-deutero-pomalidomide |
| 05/24/2012 | CA2818336A1 Agonists that enhance binding of integrin-expressing cells to integrin receptors |
| 05/24/2012 | CA2818308A1 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
| 05/24/2012 | CA2818279A1 Novel indolizine derivatives, and preparation and therapeutic use thereof |
| 05/24/2012 | CA2818229A1 Pharmaceutical combination of paclitaxel and a cdk inhibitor |
| 05/24/2012 | CA2818198A1 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 05/24/2012 | CA2818163A1 Method of treating hematological cancers |
| 05/24/2012 | CA2818144A1 Pharmaceutical compositions comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol |
| 05/24/2012 | CA2818129A1 Orally administered pharmaceutical composition for the treatment of irritable bowel syndrome, comprising an intestinal motility modifier, an agent that prevents gas retention, and digestive enzymes, and preparation method thereof |
| 05/24/2012 | CA2818125A1 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof |
| 05/24/2012 | CA2818118A1 4-substituted-3-benzyloxy-bicyclo[3.1.0]hexane compounds as mglur 2/3 antagonists |
| 05/24/2012 | CA2818116A1 4-substituted-3-phenylsulfanylmethyl-bicyclo[3.1.0]hexane compounds as mglur 2/3 antagonists |
| 05/24/2012 | CA2818097A1 Therapeutic compositions comprising rilpivirine hcl and tenofovir disoproxil fumarate |
| 05/24/2012 | CA2818046A1 Protection of renal tissues from ischemia through inhibition of the proliferative kinases cdk4 and cdk6 |
| 05/24/2012 | CA2818025A1 Pyridazine derivatives, compositions and methods for treating cognitive impairment |
| 05/24/2012 | CA2818002A1 Substituted sodium-1h-pyrazole-5-olate |
| 05/24/2012 | CA2817988A1 Benzodiazepine derivatives, compositions and methods for treating cognitive impairment |
| 05/24/2012 | CA2817982A1 Controlled release mucoadhesive systems |
| 05/24/2012 | CA2817975A1 Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells |
| 05/24/2012 | CA2817960A1 Modulation of alpha synuclein expression |
| 05/24/2012 | CA2817957A1 Substance for increasing the production of a specific acyl-chain dihydroceramide(s) for improving the effectiveness of cancer treatments |
| 05/24/2012 | CA2817931A1 2-piperazin-1-yl-4h-1,3-benzothiazin-4-one derivatives and their use forthe treatment of mammalian infections |
| 05/24/2012 | CA2817896A1 Inhibitors of hiv replication |
| 05/24/2012 | CA2817891A1 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response |
| 05/24/2012 | CA2817888A1 Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same |
| 05/24/2012 | CA2817872A1 Vasoprotective and cardioprotective antidiabetic therapy |
| 05/24/2012 | CA2817840A1 Antiviral compounds |